Anticonceptivos hormonales y migraña: evidencia y riesgos

María Augusta Reyes-Pérez, Yesenia Esthefania Arellano-Oleas, Orgel Joel Jaime-Pucuji

Texto completo:

PDF

Resumen

El presente estudio analizó la relación del uso de anticonceptivos hormonales (AH) combinados y la migraña, enfatizando la amenaza de sufrir un accidente cerebrovascular en pacientes con esta patología preexistente. Los resultados sugieren que el empleo de anticonceptivos hormonales combinados aumenta la amenaza de accidentes cerebro vasculares en mujeres con migraña, especialmente en aquellas con migraña con aura (MA). Aunque algunos estudios indican que ciertos anticonceptivos pueden aliviar los síntomas de la migraña, la evidencia es limitada y se necesita nuevos estudios para confirmar estos hallazgos. Se realizó una búsqueda retrospectiva de artículos científicos entre febrero y marzo de 2024, utilizando DeCS y motores de búsqueda académicos. Se escogieron 12 artículos, las cuales cumplían con criterios de inclusión específicos, tras un proceso de selección independiente por parte de los coautores y consenso final.

Palabras clave

ANTICONCEPTIVOS; AMENAZAS; CEREBRO; PATOLOGÍA; SIGNOS Y SÍNTOMAS.

Referencias

Thomsen AV, Ashina H, Al-Khazali HM, Rose K, Christensen RH, Amin FM, et al. Clinical features of migraine with aura: a REFORM study. J Headache Pain [Internet]. 2024 Dec 1 [cited 2024 Feb 25]; 25(1): 22. Available from: https://pubmed.ncbi.nlm.nih.gov/38350851/

Kaniecki R. Migraine with brainstem aura. Manual de Neurologia Clínica [Internet]. 2024 Jan 1 [cited 2024 Feb 25]; 199: 367–79. Available from: https://www.sciencedirect.com/science/article/abs/pii/B9780128233573000197?via%3Dihub

Morillo LE, Alarcon F, Aranaga N, Aulet S, Chapman E, Conterno L, et al. Prevalence of migraine in Latin America. Headache [Internet]. 2005 Feb [cited 2024 Feb 25]; 45(2): 106–17. Available from: https://pubmed.ncbi.nlm.nih.gov/15705115/

Chiang CC, Chen SP. Migrainous infarction. Handb Clin Neurol [Internet]. 2024 Jan 1 [cited 2024 Feb 25]; 199: 465–474. Disponible en: https://pubmed.ncbi.nlm.nih.gov/38307663/

Olesen J, André Bes D, Robert Kunkel F, James W Lance EU, Giuseppe Nappi A, Volker Pfaffenrath I, et al. III Edición de la Clasificación Internacional de las Cefaleas. Cephalalgia [Internet]. 2018 [cited 2024 Feb 25]; 38(1): 1-211. Disponible en: https://ihs-headache.org/wp-content/uploads/2020/05/3559_ichd-3-spanish.pdf

Zebenholzer K, Wöber C, Vigl M, Wessely P, Wöber-Bingöl Ç. Facial pain in a neurological tertiary care centre - Evaluation of the International Classification of Headache Disorders. Cephalalgia [Internet]. 2005 Sep [cited 2024 Feb 25]; 25(9): 689–99. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16109050/

Fleurant E, Mokashi M, Simon MA. Over-the-Counter Progestin-Only Oral Contraceptives. JAMA [Internet]. 2023 Nov 14 [cited 2024 Mar 5]; 330(18): 1810. Available from: https://jamanetwork.com/journals/jama/fullarticle/2809764

de Santana DLP, Gonçalves MB, Zimpel VMH, Figueiredo EG. Does the use of oral contraceptives or hormone replacement therapy offer protection against the formation or rupture of intracranial aneurysms in women?: a systematic review and meta-analysis. Rev Assoc Med Bras [Internet]. 2023 Aug 4 [cited 2024 Mar 5]; 69(suppl1): e2023S118. Available from: https://www.scielo.br/j/ramb/a/Sg67Sr8TFtgJB7NzK3wChrM/?lang=en

Rojo MG, Lloret MRP, Gironés JG. Oral manifestations in women using hormonal contraceptive methods: a systematic review. Clin Oral Investig [Internet]. 2024 Mar 1 [cited 2024 Mar 5]; 28(184). Available from: https://link.springer.com/10.1007/s00784-024-05573-x

van der Arend BWH, van Casteren DS, Verhagen IE, MaassenVanDenBrink A, Terwindt GM. Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!). Trials [Internet]. 2024 Dec 1 [cited 2024 Mar 5]; 25(123). Available from: https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-024-07955-8

Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, et al. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford) [Internet]. 2019 Jul 1 [cited 2024 Feb 16]; 58(7): 1259-1267. Available from: https://pubmed.ncbi.nlm.nih.gov/30753683/

Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol [Internet]. 2017 May 1 [cited 2024 Feb 27]; 216(5): 489.e1-489.e7. Available from: http://www.ajog.org/article/S0002937816462083/fulltext

Ornello R, Canonico M, Merki-Feld GS, Kurth T, Lidegaard Ø, MacGregor EA, et al. Migraine, low-dose combined hormonal contraceptives, and ischemic stroke in young women: a systematic review and suggestions for future research. Expert Rev Neurother [Internet]. 2020 Apr 2 [cited 2024 Feb 16]; 20(4): 313–7. Available from: https://www.tandfonline.com/doi/abs/10.1080/14737175.2020.1730816

Vitali-Silva A, Vuolo IG, Gonzalez LH, Galvão RF, Farges SG, Bello VA, et al. Oral combined hormonal contraceptive associated with protection against allodynia in migraine in a cross-sectional study. Ir J Med Sci [Internet]. 2023 Oct 1 [cited 2024 Feb 16]; 192(5): 2203–8. Available from: https://link.springer.com/article/10.1007/s11845-023-03293-x

Batur P, Yao M, Bucklan J, Soni P, Suneja A, Farrell R, et al. Use of combined hormonal contraception and stroke: A case-control study of the impact of migraine type and estrogen dose on ischemic stroke risk. Headache: The Journal of Head and Face Pain [Internet]. 2023 Jun 1 [cited 2024 Feb 16]; 63(6): 813–21. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/head.14473

Merki-Feld GS, Imthurn B, Gantenbein AR, Sandor P. Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial. European Journal of Contraception and Reproductive Health Care [Internet]. 2019 May 4 [cited 2024 Feb 16]; 24(3): 175–81. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31094588/

Bugge NS, Grøtta Vetvik K, Alstadhaug KB, Braaten T. Cumulative exposure to estrogen may increase the risk of migraine in women. Cephalalgia [Internet]. 2024 Jan 12 [cited 2024 Feb 27]; 44(1). Available from: https://journals.sagepub.com/doi/10.1177/03331024231225972

Voedisch AJ, Hindiyeh N. Combined hormonal contraception and migraine: Are we being too strict? Curr Opin Obstet Gynecol [Internet]. 2019 Dec 1 [cited 2024 Feb 24]; 31(6): 452–8. Available from: https://journals.lww.com/co-obgyn/fulltext/2019/12000/combined_hormonal_contraception_and_migraine__are.14.aspx

Alet M, Rosales J, Claverie S, González L, Lepera S, Rey R. Accidente cerebrovascular isquémico en paciente joven asociado a aneurisma del septo interauricular multifenestrado. Neurología Argentina [Internet]. 2018 Apr 1 [cited 2024 Feb 24]; 10(2): 110–114. Disponible en: https://www.elsevier.es/es-revista-neurologia-argentina-301-articulo-accidentecerebrovascular-isquemico-paciente-joven-S1853002817300174

Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain [Internet]. 2017 Dec 1 [cited 2024 Feb 27]; 18(1): 108. Available from: https://pubmed.ncbi.nlm.nih.gov/29086160/

Calhoun AH, Batur P. Combined hormonal contraceptives and migraine: An update on the evidence. Cleve Clin J Med [Internet]. 2017 Aug 1 [cited 2024 Feb 27]; 84(8): 631–638. Available from: https://pubmed.ncbi.nlm.nih.gov/28806162/

Lima ACS, Martins LCG, Lopes MV de O, Araújo TL de, Lima FET, Aquino P de S, et al. Influence of hormonal contraceptives and the occurrence of stroke: integrative review. Rev Bras Enferm [Internet]. 2017 May 1 [cited 2024 Feb 27]; 70(3): 647–55. Available from: https://www.scielo.br/j/reben/a/stgG6mmLJjcWf4NMmrmvk7q/?lang=en

Enlaces refback

  • No hay ningún enlace refback.


Bookmark and Share


Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional.